Details of the Drug

General Information of Drug (ID: DMJBZ8N)

• Drug Name: Carbetapentane
• Synonyms: Carbetapentane citrate; Pentoxyverine citrate; 23142-01-0; Loucarbate; Pentoxiverine citrate; Carbetapentane citrate salt; Toclase; Toclase citrate; Carbetapentone citrate; Carbetapentane (citrate); UNII-4SH0MFJ5HJ; Carbetapentane citrate [NF]; EINECS 245-449-5; 4SH0MFJ5HJ; 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate citrate; 2-(2(Diethylamino)ethoxy)ethyl 1-phenyl-cyclopentanecarboxylate citrate (1:1); 2-(2-(Diethylamino)ethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate dihydrogen citrate; Ethanol, 2-(2-(die

Indication

Disease Entry	ICD 11	Status	REF
Cough	MD12	Approved	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C20H31NO3
  Canonical SMILES: CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2
  InChI: InChI=1S/C20H31NO3/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3
  InChIKey: CFJMRBQWBDQYMK-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 2562
  ChEBI ID: CHEMBL73234
  CAS Number: 77-23-6
  UNII: 32C726X12W
  DrugBank ID: DB11186
  TTD ID: D09VBC
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug Pharmacogenomic Perturbation (DPP)NEW: Click to Jump to the Detailed DPP Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015